Biomolecular and Safety Considerations of Phytopharmaceuticals

Rakesh Kumar Tekade is a distinguished pharmaceutical scientist and Professor in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad. His career spans over a decade of academic and research excellence across India, the USA, the UK, and Malaysia. Dr. Tekade is a recipient of numerous prestigious awards, including the Commonwealth Fellowship (UK), National Doctoral Fellowship (AICTE-NDF), Irish Government Postdoctoral Award (IRISH-PDF), CSIR-SRF, AICTE-JRF, and the Troikaa Pharm Innova Award. His research focuses on the development of translational and targeted nano-biomaterials for biomedical applications. He has co-authored over 400 publications (with more than 18000+ citations and an H-index of 67), edited 12 reference books, and holds 12 patents, as well as one technology transfer to his credit. Dr. Tekade has been recognized as a top 2% researcher in pharmacy and pharmacology by Stanford University and Elsevier. Dr. Tekade has supervised numerous postdoctoral researchers, Ph.D. students, and master’s students and is the principal investigator for DST, DBT, and ICMR-funded projects. He has also served on various nationally and internationally recognized committees and as a reviewer for multiple international journals and grant agencies.Shailendra Saraf is a notable expert and a renowned academician in the Arena of Pharmaceutical Disciplines. As the Director of the National Institute of Pharmaceutical Education and Research, Ahmedabad, he leverages his extensive experience in academic leadership. Dr. Saraf has played a pivotal role in various national, statutory, regulatory, and accreditation bodies and maintains active connections with several national and international professional organizations. He has successfully completed multiple research projects funded by national extramural funding agencies and supervised over a dozen Ph.D. candidates. He has authored over 200 research/review papers, filed 10 patents, garnered more than 10,000 citations, and has an H-index of 46. He is on editorial boards and a reviewer for numerous national and international journals. He has delivered keynote speeches and chaired sessions in various seminars, conferences, and workshops globally.Swarnlata Saraf is a dedicated academician and researcher in pharmaceutical sciences, serving as a professor at the University Institute of Pharmacy,Pt. Ravishankar Shukla University,Raipur. With a strong academic foundation from IIT-BHU and Dr. H S Gour University, she has guided 19 PhD and 41 PG students, authored fifteen books and published over 350 publications to her credit. Prof Swarnlata Saraf has an impressive 12000+ citations and an H-index of 52. Her work in nanotechnology, drug delivery and cosmetic technology has earned national and international recognition including government funded projects. Passionate about innovation, she continues to contribute to the advancement of pharmaceutical sciences worldwide.

• Chapter 1: Current Trends and Scope in Phytopharmaceutical Research. Chapter 2: Ancient and Modern Practices in Phytomedicine in Various Continents. Chapter 3: Screening, Extraction, and Purification of Phytopharmaceuticals. Chapter 4: Identification, Standardization, and Quality Control of Herbal Preparations. Chapter 5: High-Throughput Screening in Phytomedicine Discovery. Chapter 6: Omics Integrated Phytomedicine Research. Chapter 7: Integration of Artificial Intelligence in Phytomedicine Research. Chapter 8: Biomechanics of Phyto-Compounds as Anti-Pathogenic Agents. Chapter 9: Therapeutic Applications of Herbal Medicines. Chapter 10: Strategy to Target Bacteria and Virulence Using Phytomedicines. Chapter 11: Microalgae Metabolites in the Pharmaceutical Industry. Chapter 12: Potential Nanostructured Strategies for the Delivery of Phytochemical Compounds. Chapter 13: Challenges and Delivery Avenues of Phytomedicine. Chapter 14: Effect of Herb-Drug Interaction on Bioactivity and Safety Aspects of Phytomedicine. Chapter 15: Biopharmaceutical Challenges Associated with Phytomedicine. Chapter 16: Safety and Toxicology Considerations of Phytomedicine. Chapter 17: Public Perception of Herbal Medicines. Chapter 18: Translational Case Studies on Marketed Phytomedicines: From Traditional Knowledge to Global Therapeutics. Chapter 19: Towards Approaching Next-Generation Phytopharmaceuticals.